NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/25/2025
Back to search
Official data from USPTO
WHITELAB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
02/25/2025
Trademark type
Word
Nice classes
42
Filing date
10/04/2023
Registration date
02/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/25/2025
Last transaction
02/25/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Cedex, FR
Examiner
REYNOLDS,DYLAN M
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
W. G. (pessoa física)
Representatives
Pina Campagna CARTER, DELUCA, AND FARRELL, LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific research and development; Research services and development of new products for third parties; Industrial research in the field of biology; Industrial and pharmaceutical development in the field of human biology and diseases; scientific research in the field of genetics; Biological research; Technical research in the field of field of geneticsmedical devicesgenomic medicinegenetic engineeringsynthetic biologydata scienceartificial intelligence; Scientific and technical research and development in the field of geneticsmedical devicesgenetic engineeringsynthetic biologyartificial intelligence; Research and development of medical devices; engineering services in the field of genetics; Scientific research services relating to the isolation and culture of human tissues and cells; scientific and medical research and development in the field of tissue manufacturing; research in the field of regenerative biotherapiesgenomics; research and development of new products in the field of regenerative biotherapiesgenomicsbiotechnologychemicals and pharmaceuticals; scientific research and development for medical purposes; consulting services in scientific and industrial research; engineering in the medical field; design of diagnostic medical equipment and medical devices; computer-assisted diagnostic testing services for others for scientific research purposes; computer diagnostic services; designdevelopment and maintenance of software and mobile applications for use in medical technologies; conversion of data or documents from physical to electronic media; Software as a Service featuring software for use in searchingtrackingexploration and analysis of data for use in the field of pharmaceuticals and medicines in the medical field; Computer Platform as a Service featuring software for use in searchingtrackingexploration and analysis of data for use in the field of pharmaceuticals and medicines in the medical field; Biopharmaceutical and pharmaceutical research services; Scientific research related to drugsbiopharmaceuticals and pharmaceuticalspharmaceutical drugs and biopharmaceutical drugs; Research and development in the field of diagnostic preparations; Research and development services in the field of medical diagnostic tools and software design; computer software designdevelopmentinstallationupdating; electronic data storage in the field of DNA sequencing for diagnostic and therapeutic purposes; technical data analysis in the field of DNA sequencing for diagnostic and therapeutic purposes; IT consulting services relating to on-line searchable databases and algorithms for the management and delivery of scientific analysis results based on genomic data; rental and maintenance of software for searchingtrackingexploration and analysis of data for use in the field of pharmaceuticals and medicines; rental of computer hardware; rental of scientific instruments; rental of laboratory apparatus and instruments; design and development of software for use in medical technologies; development and testing of methodsalgorithmscomputer software in the field of multi-omics data including DNA and RNA sequencing; technical consulting services in the application and use of software; software engineering services for data processing programs; software engineering services; software as a service (SAAS) services featuring software platforms for use in artificial intelligenceall of the aforesaid in the field of DNA sequencingmedical diagnosticsgeneticsgenetic engineering
Publications
History of USPTO decisions and trademark events.
18 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
02/25/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/07/2025
PUBO
PUBLISHED FOR OPPOSITION
01/07/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/01/2025
CHPB
POST PUBLICATION AMENDMENT - ENTERED
12/18/2024
APET
ASSIGNED TO PETITION STAFF
12/17/2024
PPAR
POST PUBLICATION AMENDMENT RECEIVED
06/13/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
06/13/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
06/13/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
06/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
06/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/06/2024
DOCK
ASSIGNED TO EXAMINER
05/23/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/13/2023
NWAP
NEW APPLICATION ENTERED
10/07/2023
Continuous trademark protection
Get notified about every new filing that threatens WHITELAB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.